CVS Health stock was falling after lowered cash-flow guidance overshadowed better-than-expected fourth-quarter earnings Wednesday.
The pharmacy chain reported fourth-quarter revenue of $76.6 billion, beating the FactSet consensus of $75.6 billion. Adjusted earnings per share were $1.98, which topped the FactSet consensus of $1.83.
But CVS…